TRPC6 and congestive heart failure: Transient receptor potential 6 (TRPC6) gene alterations are putative risks for chemotherapy-induced congestive heart failure, and TRPC6 N338S is a gain-of-function mutant that may lead to DIC by increasing Ca2+ influx within cardiomyocytes [34•].